logo
logo
Community
Pricing
Sign in
menu-h

Global Genomic Workstation Market Research Report 2021

avatar
riya singh
Global Genomic Workstation Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-genomic-workstation-2021-23



  • Fully Automatic
  • Semi Automatic


Segment by Application


  • Laboratory
  • Clinical
  • Pharmaceutical
  • Others




By Region


  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE


By Company


  • Danaher Corporation (Beckman Coulter)
  • Aurora
  • Synthetic Genomics, Inc.
  • PerkinElmer Inc.
  • Fluent
  • Tecan Group
  • Thermo Scientific
  • Hudson Robotics
  • LGC Ltd
  • Endress+Hauser (Analytik Jena)

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-genomic-workstation-2021-23


Table of content

1 Genomic Workstation Market Overview

1.1 Product Overview and Scope of Genomic Workstation

1.2 Genomic Workstation Segment by Type

1.2.1 Global Genomic Workstation Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 Fully Automatic

1.2.3 Semi Automatic

1.3 Genomic Workstation Segment by Application

1.3.1 Global Genomic Workstation Sales Comparison by Application: (2021-2027)

1.3.2 Laboratory

1.3.3 Clinical

1.3.4 Pharmaceutical

1.3.5 Others

1.4 Global Genomic Workstation Market Size Estimates and Forecasts

1.4.1 Global Genomic Workstation Revenue 2016-2027

1.4.2 Global Genomic Workstation Sales 2016-2027

1.4.3 Genomic Workstation Market Size by Region: 2016 Versus 2021 Versus 2027


2 Genomic Workstation Market Competition by Manufacturers

2.1 Global Genomic Workstation Sales Market Share by Manufacturers (2016-2021)

2.2 Global Genomic Workstation Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Genomic Workstation Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Genomic Workstation Manufacturing Sites, Area Served, Product Type

2.5 Genomic Workstation Market Competitive Situation and Trends

2.5.1 Genomic Workstation Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Genomic Workstation Players Market Share by Revenue

2.5.3 Global Genomic Workstation Market Share

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170 / +91 8087042414

Email: [email protected]


Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/

collect
0
avatar
riya singh
Related Articles
Global Genomic Biomarkers Market Size and Share Report 2028 | Growth Market Reports
Sheryl Dias 2022-04-18
img
The global genomic biomarkers market is estimated to expand at a substantial CAGR during the forecast period, 2021-2028. Diagnostic & Research Laboratories to occupy significant market shareIn terms of end users, the global genomic biomarkers market can be divided into diagnostic & research laboratories, hospitals, and others. Major players in the global genomic biomarkers market include Alma Group, Beckman Coulter, Inc. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. comFollow Us: LinkedIn | Twitter 
collect
0
Genomic Biomarkers Market Scope, Overview, Opportunities And Forecast to 2032
Soffi Clark 2023-05-23
img
According to the research report published by Polaris Market Research, the Global Genomic Biomarkers Market Size Is Expected To Reach USD 10. Polaris Market Research recently released a new report titled "Genomic Biomarkers Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2032," available in its online repository. The market in each geography is examined, along with its size, Genomic Biomarkers Market share in the regional and national breakdowns section. com/industry-analysis/genomic-biomarkers-marketAbout Us:Polaris Market Research is a worldwide market research and consulting organization. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
collect
0
Genomic Biomarker Market ,Market Overview,Key Trends
Pooja Khodke 2023-11-20
img
Based on application, the oncology segment is expected to be the fastest-growing segment in the genomic biomarker market. Key Takeaways:The Global Genomic Biomarker Market Demand is expected to witness high growth, exhibiting a CAGR of 9. In terms of regional analysis, North America is the fastest-growing and dominating region in the genomic biomarker market. Key players operating in the genomic biomarker market include Thermo Fisher Scientific, F. The competitive landscape of the genomic biomarker market is characterized by intense competition due to the presence of several established and emerging players.
collect
0
Genomic Biomarkers Market | Global Industry Trends, Segmentation, Business Opportunities & Forecast To 2030
Suman Singh 2023-09-20
img
The new Genomic Biomarkers Market report offers a comprehensive study of the current scenario of the market including major market dynamics. Get more information on "Global Genomic Biomarkers Market Research Report" by requesting FREE Sample Copy at https://www. Additionally, these tools also give an inclusive assessment of each segment in the global market of genomic biomarkers. Browse Global Genomic Biomarkers Market Research Report with detailed TOC at https://www. Purchase Complete Global Genomic Biomarkers Market Research Report at https://www.
collect
0
Genomic Biomarker Market to Reach US$ 4,396.6 Mn in 2023
Ashish Thapa 2023-10-19
img
The global Genomic Biomarker Market Share is estimated to be valued at Us$ 4,396. Based on application, the oncology segment is expected to be the fastest-growing segment in the genomic biomarker market. Key Takeaways: The global genomic biomarker market is expected to witness high growth, exhibiting a CAGR of 9. In terms of regional analysis, North America is the fastest-growing and dominating region in the genomic biomarker market. The competitive landscape of the genomic biomarker market is characterized by intense competition due to the presence of several established and emerging players.
collect
0
Tumor Genomics Market Size, Trends, Revenue Share Analysis, Forecast, 2021–2028
Tani Shah 2023-06-20
img
The Tumor Genomics Market research report is a comprehensive and vital document encompassing business strategies, qualitative and quantitative analysis, and emerging trends of the global Tumor Genomics market. The global tumor genomics market is expected to reach a market size of 56. The report also includes revenue estimations and CAGR of the Tumor Genomics market in the coming years. 1 Global Tumor Genomics market size2. com/insightsExplore Our Custom Intelligence services | Growth Consulting Services 
collect
0
WHO TO FOLLOW
MORE FROM AUTHOR
Telecommunication Software Used for Fiber Management Market, Global Outlook and Forecast 2022-2028
riya singh 2022-04-07
img
collect
0
Fiber Management Solutions Market, Global Outlook and Forecast 2022-2028
riya singh 2022-04-07
img
collect
0
Fiber Management Software Market, Global Outlook and Forecast 2022-2028
riya singh 2022-04-07
img
collect
0
Electronic Pedicure Tools Market, Global Outlook and Forecast 2022-2028
riya singh 2022-04-07
img
collect
0
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more
WHO TO FOLLOW
Press enter to search  enter
articles
Genomic Biomarker Market Is Estimated To Witness High Growth Owing To Increasing Demand for Precision Medicine
Anjali Pawar 2023-09-05
img
The global Genomic Biomarker market is estimated to be valued at US$ 4,396. This market has witnessed tremendous growth due to the increasing demand for precision medicine and personalized treatment options. - Economic: The Genomic Biomarker Market is driven by factors such as increased healthcare spending, rising adoption of personalized medicine, and advancements in genomic technologies. The global genomic biomarker market is expected to witness high growth, exhibiting a CAGR of 9. In conclusion, the genomic biomarker market is poised for significant growth in the coming years due to increasing demand for precision medicine and personalized treatment options.
collect
0
Genomic Tests Market : Features, Opportunities and Challenges | ViaCord, Genova Diagnostics (GDX), Fulgent Genetics, Loxo Oncology, Color
Diana Rusco 2021-11-25
img
This Genomic Tests market report is a total overview of the market that takes into account various aspects of product definition, market segmentation, and the existing merchant landscape. The genomic tests market is expected to witness market growth at a rate of 10. dbmr=global-genomic-tests-marketGenomic Tests Market Scope and Market SizeThe genomic tests market is segmented on the basis of type, technology, application and end user. On the basis of application, the genomic tests market is segmented into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis and others. com/reports/global-genomic-tests-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
collect
0
Crispr Genomic Cure Market Is Estimated To Witness High Growth Owing To Opportunity Of Genome Editing For Complex Diseases
Poonam 2024-01-18
img
The CRISPR-genomic cure market involves the development of therapies and drugs that use CRISPR-Cas genome editing technology to cure complex diseases by modifying the human genome. The global Crispr Genomic Cure Market is estimated to be valued at US$ 1. Key Takeaways The global CRISPR Genomic Cure Market growth is expected to witness high growth over the forecast period of 2023 to 2030. The global Crispr Genomic Cure Market is estimated to be valued at US$ 1. The development of CRISPR therapies is in early stages currently with a few therapies in clinical trials. Key players: Key players operating in the Crispr genomic cure market include Crispr Therapeutics, Intellia Therapeutics, Editas Medicine, Marriott International, Hilton Worldwide Holdings Inc.
collect
0
Genomic Biomarker Market Regional Insights And Forecast 2021-2028
Rahul Kumar Yadav 2023-07-19
img
The Genomic Biomarker Market has witnessed substantial growth in recent years, driven by increasing applications of genomics in personalized medicine and drug development. These countries have made significant investments in genomic research and have a strong focus on developing targeted therapies based on genetic information. In Europe, the Genomic Biomarker Market is also flourishing, with countries like the United Kingdom, Germany, and France at the forefront of genomics research. The Genomic Biomarker Market future growth prospects are not without challenges, including ethical considerations related to genetic testing, data privacy concerns, and regulatory frameworks that vary across different regions. The Genomic Biomarker Market exhibits robust growth across different regions, with North America leading the way due to its well-established life sciences industry and supportive regulatory environment.
collect
0
Genomic Biomarker Market Growth Accelerated By Increased Funding In Genomic Research
Dhanesha Patil 2024-01-18
img
The growing burden of chronic diseases such as cancer has increased the funding for genomic research which is driving the growth of the genomic biomarker market. National Institutes of Health (NIH) funded close to US$ 6 billion for genomic research in 2022 alone which is expected to drive the use of genomic biomarkers in research. The increased integration of genomic data with electronic health records by healthcare providers is also enabling widespread use of genomic biomarkers. Regional analysis: North America currently dominates the global genomic biomarker market owing to increasing adoption of companion diagnostics and growing funding for genomic research in the region. , Eckert & Ziegler BEBIG are some of the prominent players operating in the genomic biomarker market.
collect
0
Genomic Cancer Testing Market is Estimated to Witness High Growth Owing to Opportunity to Drive Personalized Medicine
Lucy Kart 2024-02-07
img
The global Genomic Cancer Testing Market is estimated to be valued at US$ 14. With continuous advancements in precision oncology, genomic cancer testing is poised to play a pivotal role in driving wider adoption of personalized medicine approaches in cancer treatment over the coming years. Growing demand for personalized cancer treatment. Key Takeaways Global Genomic Cancer Testing Market Demand is expected to witness high growth during the forecast period of 2024-2031. Key players operating in the genomic cancer testing market are Myriad Genetics, Illumina, Roche, Qiagen, Thermo Fisher Scientific, among others.
collect
0
Crispr Genomic Cures is Estimated to Witness High Growth Owing to Opportunity of Treating Rare Genetic Diseases
Mia Yates 2023-12-19
img
The global Crispr genomic cure Market is estimated to be valued at US$ 1. Many rare genetic diseases lack effective treatment options as conventional drug development is often not commercially viable for such small patient populations. Key Takeaways The Global CRISPR Genomic Cure Market Size is expected to witness high growth led by rising incidence of genetic diseases and increasing product approvals. Regional analysis: North America currently dominates the Crispr genomic cure market led by the US contributing more than 35% of global revenues. Key players operating in the Crispr genomic cure market are CRISPR Therapeutics AG, Editas Medicine, Inc.
collect
0
BIS Research Study Highlights the Global Genomic Data Analysis and Interpretation Market to Reach $2.10 Billion by 2030
bisresearch reports 2022-03-02
img
The global genomic data analysis and interpretation market is projected to reach $2. The application and the region segment have been further sub-segmented to offer an in-depth analysis of the global genomic data analysis and interpretation market. What are the major market drivers, challenges, and opportunities in the global genomic data analysis and interpretation market? Who are the leading players with significant offerings to the global genomic data analysis and interpretation market? BIS Research Related Market Studies:Global NGS Informatics and Clinical Genomics Market – Analysis and Forecast, 2018-2028Global Next-Generation Sequencing Market – Analysis and Forecast, 2019-2024  
collect
0
CRISPR Genomic Cure Market Propelled By Adoption Of Crispr Genomic Cures For Chronic Diseases
kiran gire 2024-01-29
img
The global Crispr Genomic Cure Market is estimated to be valued at US$ 1. Key Takeaways The global Crispr genomic cure market analysis is expected to witness high growth. Regional analysis: North America is expected to dominate the global Crispr genomic cure market during the forecast period. Rising cases of genetic diseases and increasing investments in genomic cure technology development by governments are also supporting market growth. Key playersoperating in the Crispr genomic cure market are Marriott International, Hilton Worldwide Holdings Inc.
collect
0
Advancing Lung Cancer Care through Genomic Testing: Industry Report (2021-2031)
Tanzeel Obaid 2023-05-16
img
Traditionally, lung cancer was classified based on histology, which divided the disease into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). However, genomic testing has shown that lung cancer is a highly diverse disease, with several subtypes having distinct genomic profiles. Benefits of Genomic Testing in Lung Cancer Accurate Diagnosis and Subtyping: Genomic testing provides a more precise and accurate diagnosis by identifying the specific subtype of lung cancer. According to BIS Research, The Lung Cancer Genomic Testing Medicine Market was valued at $1,262. Additionally, specialized companies like Foundation Medicine and Guardant Health focus specifically on genomic profiling and provide comprehensive panels for lung cancer genomic testing.
collect
0
Global Genomic Cancer Panel and Profiling Market Size, Overview, Key Players and Forecast 2028
shraddha surkute 2022-12-20
img
Global Genomic Cancer Panel and Profiling Market is anticipated to reach a value of over USD xx billion by 2028 and register a CAGR of xx% for the forecast period 2022-2028. FutureWise Research has released a research report that analyses Genomic Cancer Panel and Profiling Market trends in order to forecast market growth. The Genomic Cancer Panel and Profiling Market report examines market segmentation forecasts by type of cancer, by type of application, by tissue type, and by region. Competitive Landscape:·        Tier one players - major players with a substantial market share. Flexible Delivery Model:•       We provide a flexible distribution strategy where you may suggest changes to the information's scope or table in accordance with your demands.
collect
0
Genomic Cancer Testing Market Growth Accelerated by Early Detection and Personalized Treatment
Ishika cmi 2024-02-08
img
The global Genomic Cancer Testing Market is estimated to be valued at US$ 18. Ongoing R&D to discover new cancer biomarkers is also expanding clinical applications of genomic cancer testing. Segment Analysis Genomic Cancer Testing Market The global genomic cancer testing market size is dominated by the breast cancer sub-segment, owing to the increasing prevalence and incidence rates. Key Takeaways The global Genomic Cancer Testing market is expected to witness high growth over the forecast period. Key players operating in the Genomic Cancer Testing market are Bitmain Technologies, MicroBT, Canaan Creative, NVIDIA, AMD, Genesis Mining, Bitfury Group, Hut 8 Mining Corp.
collect
0
Global Genomic Cancer Testing Market Is Estimated To Witness High Growth Owing To Increasing Demand For Personalized Medicine
sachin sadgir 2023-08-28
img
The Global Genomic Cancer Testing Market Is Estimated To Be Valued At US$16. B) Market Key Trends: One Key Trend In The Genomic Cancer Testing Market Is The Increasing Demand For Personalized Medicine. Technological: Rapid Advancements In Genomic Sequencing Technologies, Such As Next-Generation Sequencing, Have Significantly Improved The Accuracy And Efficiency Of Genomic Cancer Testing. D) Key Takeaways: 1: The Global Genomic Cancer Testing Market Is Expected To Witness High Growth, Exhibiting A CAGR Of 16. In Conclusion, The Global Genomic Cancer Testing Market Is Expected To Witness Significant Growth In The Coming Years, Driven By The Increasing Demand For Personalized Medicine And Advancements In Genomic Sequencing Technologies.
collect
0
Genomic Cancer Testing: Unlocking Answers for More Personalized Treatment
Nishant 2024-04-15
img
What Types of Genomic Testing Are Used in Cancer Care? What Information Can Genomic Testing Reveal for Cancer Patients? Identification of Rare Genomic Alterations Rare genomic variants that may be druggable targets can be discovered through comprehensive genomic profiling techniques. Paired with constantly improving interpretation and clinical validation, genomic testing promises to transform cancer care into a form of personalized medicine. Get more insights on Genomic Cancer Testing
collect
0
Genomic Biomarker Market Is Estimated To Witness High Growth Owing To Increasing Demand for Precision Medicine
Anjali Pawar 2023-09-05
img
The global Genomic Biomarker market is estimated to be valued at US$ 4,396. This market has witnessed tremendous growth due to the increasing demand for precision medicine and personalized treatment options. - Economic: The Genomic Biomarker Market is driven by factors such as increased healthcare spending, rising adoption of personalized medicine, and advancements in genomic technologies. The global genomic biomarker market is expected to witness high growth, exhibiting a CAGR of 9. In conclusion, the genomic biomarker market is poised for significant growth in the coming years due to increasing demand for precision medicine and personalized treatment options.
CRISPR Genomic Cure Market Propelled By Adoption Of Crispr Genomic Cures For Chronic Diseases
kiran gire 2024-01-29
img
The global Crispr Genomic Cure Market is estimated to be valued at US$ 1. Key Takeaways The global Crispr genomic cure market analysis is expected to witness high growth. Regional analysis: North America is expected to dominate the global Crispr genomic cure market during the forecast period. Rising cases of genetic diseases and increasing investments in genomic cure technology development by governments are also supporting market growth. Key playersoperating in the Crispr genomic cure market are Marriott International, Hilton Worldwide Holdings Inc.
Genomic Tests Market : Features, Opportunities and Challenges | ViaCord, Genova Diagnostics (GDX), Fulgent Genetics, Loxo Oncology, Color
Diana Rusco 2021-11-25
img
This Genomic Tests market report is a total overview of the market that takes into account various aspects of product definition, market segmentation, and the existing merchant landscape. The genomic tests market is expected to witness market growth at a rate of 10. dbmr=global-genomic-tests-marketGenomic Tests Market Scope and Market SizeThe genomic tests market is segmented on the basis of type, technology, application and end user. On the basis of application, the genomic tests market is segmented into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis and others. com/reports/global-genomic-tests-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
Advancing Lung Cancer Care through Genomic Testing: Industry Report (2021-2031)
Tanzeel Obaid 2023-05-16
img
Traditionally, lung cancer was classified based on histology, which divided the disease into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). However, genomic testing has shown that lung cancer is a highly diverse disease, with several subtypes having distinct genomic profiles. Benefits of Genomic Testing in Lung Cancer Accurate Diagnosis and Subtyping: Genomic testing provides a more precise and accurate diagnosis by identifying the specific subtype of lung cancer. According to BIS Research, The Lung Cancer Genomic Testing Medicine Market was valued at $1,262. Additionally, specialized companies like Foundation Medicine and Guardant Health focus specifically on genomic profiling and provide comprehensive panels for lung cancer genomic testing.
Crispr Genomic Cure Market Is Estimated To Witness High Growth Owing To Opportunity Of Genome Editing For Complex Diseases
Poonam 2024-01-18
img
The CRISPR-genomic cure market involves the development of therapies and drugs that use CRISPR-Cas genome editing technology to cure complex diseases by modifying the human genome. The global Crispr Genomic Cure Market is estimated to be valued at US$ 1. Key Takeaways The global CRISPR Genomic Cure Market growth is expected to witness high growth over the forecast period of 2023 to 2030. The global Crispr Genomic Cure Market is estimated to be valued at US$ 1. The development of CRISPR therapies is in early stages currently with a few therapies in clinical trials. Key players: Key players operating in the Crispr genomic cure market include Crispr Therapeutics, Intellia Therapeutics, Editas Medicine, Marriott International, Hilton Worldwide Holdings Inc.
Global Genomic Cancer Panel and Profiling Market Size, Overview, Key Players and Forecast 2028
shraddha surkute 2022-12-20
img
Global Genomic Cancer Panel and Profiling Market is anticipated to reach a value of over USD xx billion by 2028 and register a CAGR of xx% for the forecast period 2022-2028. FutureWise Research has released a research report that analyses Genomic Cancer Panel and Profiling Market trends in order to forecast market growth. The Genomic Cancer Panel and Profiling Market report examines market segmentation forecasts by type of cancer, by type of application, by tissue type, and by region. Competitive Landscape:·        Tier one players - major players with a substantial market share. Flexible Delivery Model:•       We provide a flexible distribution strategy where you may suggest changes to the information's scope or table in accordance with your demands.
Genomic Biomarker Market Regional Insights And Forecast 2021-2028
Rahul Kumar Yadav 2023-07-19
img
The Genomic Biomarker Market has witnessed substantial growth in recent years, driven by increasing applications of genomics in personalized medicine and drug development. These countries have made significant investments in genomic research and have a strong focus on developing targeted therapies based on genetic information. In Europe, the Genomic Biomarker Market is also flourishing, with countries like the United Kingdom, Germany, and France at the forefront of genomics research. The Genomic Biomarker Market future growth prospects are not without challenges, including ethical considerations related to genetic testing, data privacy concerns, and regulatory frameworks that vary across different regions. The Genomic Biomarker Market exhibits robust growth across different regions, with North America leading the way due to its well-established life sciences industry and supportive regulatory environment.
Genomic Biomarker Market Growth Accelerated By Increased Funding In Genomic Research
Dhanesha Patil 2024-01-18
img
The growing burden of chronic diseases such as cancer has increased the funding for genomic research which is driving the growth of the genomic biomarker market. National Institutes of Health (NIH) funded close to US$ 6 billion for genomic research in 2022 alone which is expected to drive the use of genomic biomarkers in research. The increased integration of genomic data with electronic health records by healthcare providers is also enabling widespread use of genomic biomarkers. Regional analysis: North America currently dominates the global genomic biomarker market owing to increasing adoption of companion diagnostics and growing funding for genomic research in the region. , Eckert & Ziegler BEBIG are some of the prominent players operating in the genomic biomarker market.
Genomic Cancer Testing Market Growth Accelerated by Early Detection and Personalized Treatment
Ishika cmi 2024-02-08
img
The global Genomic Cancer Testing Market is estimated to be valued at US$ 18. Ongoing R&D to discover new cancer biomarkers is also expanding clinical applications of genomic cancer testing. Segment Analysis Genomic Cancer Testing Market The global genomic cancer testing market size is dominated by the breast cancer sub-segment, owing to the increasing prevalence and incidence rates. Key Takeaways The global Genomic Cancer Testing market is expected to witness high growth over the forecast period. Key players operating in the Genomic Cancer Testing market are Bitmain Technologies, MicroBT, Canaan Creative, NVIDIA, AMD, Genesis Mining, Bitfury Group, Hut 8 Mining Corp.
Genomic Cancer Testing Market is Estimated to Witness High Growth Owing to Opportunity to Drive Personalized Medicine
Lucy Kart 2024-02-07
img
The global Genomic Cancer Testing Market is estimated to be valued at US$ 14. With continuous advancements in precision oncology, genomic cancer testing is poised to play a pivotal role in driving wider adoption of personalized medicine approaches in cancer treatment over the coming years. Growing demand for personalized cancer treatment. Key Takeaways Global Genomic Cancer Testing Market Demand is expected to witness high growth during the forecast period of 2024-2031. Key players operating in the genomic cancer testing market are Myriad Genetics, Illumina, Roche, Qiagen, Thermo Fisher Scientific, among others.
Global Genomic Cancer Testing Market Is Estimated To Witness High Growth Owing To Increasing Demand For Personalized Medicine
sachin sadgir 2023-08-28
img
The Global Genomic Cancer Testing Market Is Estimated To Be Valued At US$16. B) Market Key Trends: One Key Trend In The Genomic Cancer Testing Market Is The Increasing Demand For Personalized Medicine. Technological: Rapid Advancements In Genomic Sequencing Technologies, Such As Next-Generation Sequencing, Have Significantly Improved The Accuracy And Efficiency Of Genomic Cancer Testing. D) Key Takeaways: 1: The Global Genomic Cancer Testing Market Is Expected To Witness High Growth, Exhibiting A CAGR Of 16. In Conclusion, The Global Genomic Cancer Testing Market Is Expected To Witness Significant Growth In The Coming Years, Driven By The Increasing Demand For Personalized Medicine And Advancements In Genomic Sequencing Technologies.
Crispr Genomic Cures is Estimated to Witness High Growth Owing to Opportunity of Treating Rare Genetic Diseases
Mia Yates 2023-12-19
img
The global Crispr genomic cure Market is estimated to be valued at US$ 1. Many rare genetic diseases lack effective treatment options as conventional drug development is often not commercially viable for such small patient populations. Key Takeaways The Global CRISPR Genomic Cure Market Size is expected to witness high growth led by rising incidence of genetic diseases and increasing product approvals. Regional analysis: North America currently dominates the Crispr genomic cure market led by the US contributing more than 35% of global revenues. Key players operating in the Crispr genomic cure market are CRISPR Therapeutics AG, Editas Medicine, Inc.
Genomic Cancer Testing: Unlocking Answers for More Personalized Treatment
Nishant 2024-04-15
img
What Types of Genomic Testing Are Used in Cancer Care? What Information Can Genomic Testing Reveal for Cancer Patients? Identification of Rare Genomic Alterations Rare genomic variants that may be druggable targets can be discovered through comprehensive genomic profiling techniques. Paired with constantly improving interpretation and clinical validation, genomic testing promises to transform cancer care into a form of personalized medicine. Get more insights on Genomic Cancer Testing
BIS Research Study Highlights the Global Genomic Data Analysis and Interpretation Market to Reach $2.10 Billion by 2030
bisresearch reports 2022-03-02
img
The global genomic data analysis and interpretation market is projected to reach $2. The application and the region segment have been further sub-segmented to offer an in-depth analysis of the global genomic data analysis and interpretation market. What are the major market drivers, challenges, and opportunities in the global genomic data analysis and interpretation market? Who are the leading players with significant offerings to the global genomic data analysis and interpretation market? BIS Research Related Market Studies:Global NGS Informatics and Clinical Genomics Market – Analysis and Forecast, 2018-2028Global Next-Generation Sequencing Market – Analysis and Forecast, 2019-2024